Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.
Other News
Welcome or not, many of the illnesses we see in fall and winter are respiratory viruses.
Is COVID-19 over? COVID-19 continues; however, there are a few new twists:
COVID-19 rates are going up.
Please take a moment to think about what you can do to prepare to protect yourself and the people around you.